Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth
Update your Virtual Booth on PharmaCompass, ask us
About
CPhI South East AsiaCPhI South East Asia
Not Confirmed
Not Confirmed
16-18 July, 2025
Specialty & Agro Chemi...Specialty & Agro Chemical
Not Confirmed
Not Confirmed
29 June-01 July, 2025
Discovery EuropeDiscovery Europe
Not Confirmed
Not Confirmed
01-02 July, 2025
List your booth number for exhibitions, ask us
CONTACT DETAILS
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
Events
Webinars & Exhibitions
CPhI South East AsiaCPhI South East Asia
Industry Trade Show
Not Confirmed
16-18 July, 2025
Specialty & Agro Chemi...Specialty & Agro Chemical
Industry Trade Show
Not Confirmed
29 June-01 July, 2025
Discovery EuropeDiscovery Europe
Industry Trade Show
Not Confirmed
01-02 July, 2025
Digital content
INTERVIEW #SpeakPharma
[Sponsored by another company]https://www.pharmacompass.com/speak-pharma/alchem-nicselect-grants-customers-royalty-free-access-to-t-max-tech-for-3-in-1-vape-satisfaction-in-flavour-restricted-markets
VLOG #PharmaReel
[Sponsored by another company]DATA COMPILATION #PharmaFlow
[Sponsored by another company]https://www.pharmacompass.com/radio-compass-blog/j-j-s-intra-cellular-buyout-bms-oncology-gambit-sanofi-s-blueprint-acquisition-drive-mega-deals-in-h1-2025
02 Oct 2024
// FIERCE PHARMA
https://www.fiercepharma.com/pharma/bms-skates-again-64b-celgene-shareholder-lawsuit-still-not-free-another-filing
16 May 2024
// FDA
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=761136
29 Mar 2024
// REUTERS
https://www.reuters.com/business/healthcare-pharmaceuticals/bristol-myers-bowel-disease-drug-fails-meet-main-goal-late-stage-study-2024-03-28/
20 Mar 2023
// HEALTH CANADA
https://recalls-rappels.canada.ca/en/alert-recall/istodax-romidepsin-restricted-access-program
02 Mar 2023
// REUTERS
https://www.reuters.com/legal/bristol-myers-wins-dismissal-lawsuit-over-celgene-drugs-2023-03-01/
10 Feb 2023
// ECONOMIC TIMES
https://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/sun-pharma-gets-usfda-nod-to-market-generic-medication/articleshow/97795222.cms?utm_source=contentofinterest&utm_medium=text&utm_campaign=cppst
Inspections and registrations
ABOUT THIS PAGE
Celgene Corporation is a supplier offers 5 products (APIs, Excipients or Intermediates).
Find a price of Marizomib bulk offered by Celgene Corporation
Find a price of Romidepsin bulk offered by Celgene Corporation
Find a price of Apremilast bulk offered by Celgene Corporation
Find a price of Lenalidomide bulk offered by Celgene Corporation
Find a price of Thalidomide bulk offered by Celgene Corporation